Per2 deficiency in microglia alleviates motor dysfunction by inhibiting ferroptosis in spinal cord injury

Pengfei Bie1,2, Dongpo Su1, Yang Gao1,2

  • 1The First School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, PR China.

Communications Biology
|August 16, 2025
PubMed

Insights

Microglial ferroptosis, a cell death process, worsens spinal cord injury (SCI). Period 2 (Per2) protein regulates this process via the PPARα-Gpx4 pathway, offering a potential therapeutic target for SCI recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are key immune cells in the central nervous system.
  • Spinal cord injury (SCI) involves significant neuronal damage.
  • Ferroptosis, an iron-dependent cell death, contributes to neuronal loss in SCI.

Purpose of the Study:

  • Investigate the role and mechanisms of microglial ferroptosis in SCI.
  • Identify molecular regulators of microglial ferroptosis post-SCI.

Main Methods:

  • Animal models of SCI.
  • In vitro cell culture experiments.
  • RNA sequencing (RNA-seq) and coimmunoprecipitation.

Main Results:

  • Lipid droplet accumulation and ferroptosis were observed in microglia after SCI.
  • Microglial ferroptosis peaked at 3 days post-injury.
  • Microglial Period 2 (Per2) expression increased post-SCI and correlated with ferroptosis.
  • Per2 knockout in microglia improved neurological recovery by reducing ferroptosis.
  • Per2 regulated ferroptosis by downregulating Gpx4 via interaction with PPARα.

Conclusions:

  • Microglial ferroptosis is a significant contributor to SCI progression.
  • Period 2 (Per2) protein acts as a key regulator of microglial ferroptosis.
  • The Per2-PPARα-Gpx4 axis represents a potential therapeutic target for SCI treatment.